Alnylam Pharmaceuticals, Inc. (ALNY) stock prices updated...
 

Alnylam Pharmaceuticals, Inc. stock price

Alnylam Pharmaceuticals, Inc. latest news:


  • 02/01/2018 14:19:59

    BRIEF-FDA Granted Alnylam's Request For Priority Review

    Alnylam Pharmaceuticals Inc(ALNY): * ALNYLAM ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION AND PRIORITY REVIEW STATUS FOR PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS. * Alnylam Pharmaceuticals Inc(ALNY) - FDA ALSO GRANTED COMPANY'S REQUEST FOR PRIORITY REVIEW AND HAS SET AN ACTION DATE OF AUGUST 11, 2018.

  • 01/08/2018 00:23:34

    BRIEF-Sanofi And Alnylam Pharmaceuticals Enter Into Partnership

    * AND ALNYLAM, ANNOUNCED ON SUNDAY STRATEGIC RESTRUCTURING OF RNAI THERAPEUTICS RARE DISEASE ALLIANCE

  • 01/04/2018 14:13:47

    BRIEF-Alnylam Says‍ Expanded Alnylam Act Program To Include No-Charge Third-Party Genetic Testing For People At Risk ...

    Alnylam Pharmaceuticals Inc(ALNY): * ALNYLAM -‍ EXPANDS ALNYLAM ACT PROGRAM TO INCLUDE NO-CHARGE THIRD-PARTY GENETIC TESTING AND COUNSELING FOR PEOPLE AT RISK FOR ACUTE HEPATIC PORPHYRIAS​ Source text for Eikon: Further company coverage:

  • More trends:

    Alpha and Omega Semiconductor LimitedAOSL | AlphaMark Actively Managed Small Cap ETFSMCP | Alphatec Holdings, Inc.ATEC | Altera CorporationALTR | Altisource Portfolio Solutions S.A.ASPS | Altra Industrial Motion Corp.AIMC | AMAG Pharmaceuticals, Inc.AMAG | Amarin Corporation PLCAMRN | A-Mark Precious Metals, Inc.AMRK | Amaya Inc.AYA |